User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 4 results.
    • Journal article
    Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia : a randomized trial.
    Wunderink, Richard G. Laterre, Pierre-François[UCL] Francois, Bruno Perrotin, Dominique Artigas, Antonio Vidal, Luis Otero Lobo, Suzana M. Juan, Jorge San Hwang, Sung Chul Dugernier, Thierry LaRosa, Steven Wittebole, Xavier[UCL] Dhainaut, Jean-Francois Doig, Christopher Mendelson, Meryl H Zwingelstein, Christian Su, Guoqin Opal, Steven CAPTIVATE Trial Group Dive, Alain-Michel[UCL] (2011) American Journal of Respiratory and Critical Care Medicine — Vol. 183, no. 11, p. 1561-1568 (2011)
    • Journal article
    Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial.
    Dellinger, R Phillip Tomayko, John F Angus, Derek C Opal, Steven Cupo, Michael A McDermott, Sharon Ducher, Annie Calandra, Thierry Cohen, Jonathan Lipid Infusion and Patient Outcomes in Sepsis (LIPOS) Investigators Laterre, Pierre-François[UCL] (2009) Critical Care Medicine — Vol. 37, no.11, p. 2929-38 (2009)
    • Journal article
    Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis: A Randomized Controlled Trial
    OPTIMIST Trial Study Group Abraham, Edward Reinhart, Konrad Opal, Steven Demeyer, Ignace Doig, Christopher López Rodriguez, Angel Beale, Richard Svoboda, Petr Laterre, Pierre-François[UCL] Simon, Stuart Light, Bruce Spapen, Herbert Stone, Judy Seibert, Allan Peckelsen, Claus De Deyne, Cathy Postier, Russell Pettilä, Ville Sprung, Charles L. Artigas, Antonio Percell, Sandra R. Shu, Vincent Zwingelstein, Christian Tobias, Jeffrey Poole, Lona Stolzenbach, James C. Creasey, Abla A. (2003) JAMA : the journal of the American Medical Association — Vol. 290, no. 2, p. 238-247 (2003)
    • Journal article
    Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial
    Opal, Steven Laterre, Pierre-François[UCL] Abraham, Edward Francois, Bruno Wittebole, Xavier[UCL] Lowry, Stephen Dhainaut, Jean-François Warren, Brian Dugernier, Thierry Lopez, Angel Sanchez, Miguel Demeyer, Ignace Jauregui, Luis Lorente, Jose Angel McGee, William Reinhart, Konrad Kljucar, Sascha Souza, Sonia Pribble, John (2004) Critical Care Medicine — Vol. 32, no. 2, p. 332-341 (2004)